We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Next Generation Bone Graft Delivery System Resolves Unique Challenges of Minimally Invasive Spinal Surgery

By HospiMedica International staff writers
Posted on 04 Mar 2022

A next generation minimally invasive bone graft delivery system utilizes a pre-loaded bone graft cannula and a streamlined trigger-based system as a bone graft delivery solution that is optimized for the unique challenges of minimally invasive surgery. More...

Synergy Biomedical, LLC (Wayne, PA, USA) has launched the BIOSPHERE MIS II system which permits strategic and controlled placement of the company’s regarded next-generation synthetic bone graft product (BIOSPHERE PUTTY) in open, mini-open, and percutaneous minimally invasive settings. BIOSPHERE MIS II PUTTY utilizes patented bioactive glass spheres that have been shown in vivo to result in faster and more robust bone formation. The product provides surgeons with a moldable bone graft material that has one of the highest bioactive glass contents on the market.

The BIOSPHERE MIS II bone graft delivery system consists of several new innovative features such as a new hand-held dispenser, an upgraded trigger configuration, and a graft delivery cannula, pre-loaded with BIOSPHERE PUTTY. Design advances with BIOSPHERE MIS II include a new locking technology that provides audible and tactile confirmation for a secure locked connection between the cannula and dispenser. A low-profile system maximizes the surgeons’ view during graft delivery around implanted hardware and difficult to access anatomic locations. An enhanced trigger design provides surgeons with full control of BIOSPHERE PUTTY delivery volume and location. The BIOSPHERE MIS II system is a uniquely designed two-piece assembly specifically engineered for increasing efficiency in the OR.

“BIOSPHERE MIS II is a low-profile graft delivery system that allows me to place graft in difficult to access locations without obstructing my view. My favorite feature is being able to control the amount of graft that is delivered by simply deploying the trigger handle,” stated Dr. Barcohana, M.D., a spine surgeon at the Southern California Orthopedic Institute in alliance with UCLA Health). “MIS II is a Next Generation System that provides me with the solutions I need when facing the unique challenges of minimally invasive spinal surgery.”

Related Links:
Synergy Biomedical, LLC 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.